An in vitro study of renal allograft recipients for cellular delayed type hypersensitivity to glomerular basement membrane and disrupted spleen cells.
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001485:Basement Membrane / Q000276:immunology*; D002464:Cell Migration Inhibition; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007238:Infarction / Q000276:immunology; D007519:Isoantigens; D007668:Kidney / Q000098:blood supply; D007678:Kidney Glomerulus / Q000276:immunology*; D016030:Kidney Transplantation; D007962:Leukocytes / Q000276:immunology; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D013154:Spleen / Q000276:immunology*; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D007519:Isoantigens; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine